UK On A Knife Edge As Voting Begins On EU Referendum
This article was originally published in SRA
Executive Summary
As the UK goes to the polls in a once-and-for-all decision on EU membership, the stakes for the life sciences sector are high. The effects of a Brexit would be far-reaching, not only for the industry but also for other key groups such as regulators, patients and researchers.
You may also be interested in...
New EU Commissioner Outlines Plans To Tackle Shortages
The EU’s new health commissioner, Stella Kyriakides, has outlined the commission’s plans for dealing with medicines access issues in the EU member states. They include completing the review of the EU pediatric and orphan legislation and developing a new strategic plan to tackle shortages and affordability problems next year.
Scottish HTA body OKs Lynparza For Earlier Use In Ovarian Cancer
AstraZeneca’s Lynparza can now be used on the Scottish National Health Service for newly diagnosed advanced ovarian cancer.
MSF Wants Faster Deployment Of Ebola Vaccine At ‘Fair’ Price
As stockpiles of Ebola vaccine are being built up around the world, Médecins sans Frontières has said more action is needed to ensure sufficient numbers of vaccinations are available for use in current and future outbreaks.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: